Insights › Market reaction

Why Eli Lilly (LLY) Stock Fell 0.51% in 10 Minutes on Nov 17, 2026

MoveSurge measured seven earlier Eli Lilly headlines with an attributed reaction between Aug 19, 2026 and Nov 16, 2026. The largest was +0.60% in 10 minutes, on Nov 9, 2026.

Published in ET: Feed time in ET: Company news LLY -0.51% in 10 min after the headline
  • LLY fell 0.51% in the 10 minutes after the 10:42:11 ET headline, from $1,427.10 to $1,419.86.
  • The move kept building after the first minute: -0.31% at one minute, -0.51% at 10 minutes.
Market reaction bar chart for Eli Lilly: real price moves following the headline.
Real observed market reaction — release → +1m → +10m. Validated market data captured by MoveSurge.

Reaction by asset (real prices)

Asset2m beforeAt release+1m+10m+1m %+10m %
LLY 1427.10 1427.10 1422.75 1419.86 -0.31% -0.51%

Eli Lilly (LLY) shares fell 0.51% in the 10 minutes after this headline reached the MoveSurge news feed at 10:42:11 ET on Tuesday, November 17, 2026: “Eli Lilly (LLY) options: 136 Dec 18 '26 $1200 calls traded at the bid for $3.22M”

LLY in the first 10 minutes

From a reference price of $1,427.10 just before the headline, the stock was down 0.31% after one minute and down 0.51%, at $1,419.86, after 10 minutes. The move kept building after the first minute.

Earlier LLY headlines and the measured reaction

MoveSurge measured seven earlier Eli Lilly headlines with an attributed reaction between Aug 19, 2026 and Nov 16, 2026. The largest was +0.60% in 10 minutes, on Nov 9, 2026.

  1. Nov 11, 2026, 10:42 ET: “Eli Lilly (LLY) options: 140 Jan 2028 $2000 calls traded at the bid for $1.28M, above open interest of 132” (-0.38% in 10 minutes)
  2. Nov 9, 2026, 12:10 ET: “Eli Lilly spokesperson says company is carefully evaluating FDA drug-safety communication for GLP-1 RA and will respond promptly” (+0.36% in 10 minutes)
  3. Nov 9, 2026, 09:40 ET: “In a late-stage trial, Eli Lilly (LLY) says Zepbound, its obesity pill, significantly eased obstructive sleep apnea severity among patients with obesity.” (+0.60% in 10 minutes)
  4. Nov 6, 2026, 12:49 ET: “Hims & Hers partners directly with Eli Lilly on obesity drugs” (-0.35% in 10 minutes)
  5. Nov 2, 2026, 14:46 ET: “Eli Lilly (LLY) options: 250 Jan 2028 $1600 calls traded at the bid for $4.63M” (+0.28% in 10 minutes)
  6. Oct 29, 2026, 11:40 ET: “Eli Lilly reported $303 million in asset impairment, restructuring and other special charges for the three months ended Sept. 30 in an SEC filing” (+0.36% in 10 minutes)

Eli Lilly at a glance

SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
Market value$1.35 trillion (as of Nov 18, 2026)

Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.

What headline moved Eli Lilly stock on November 17, 2026?

At 10:42:11 ET, this headline crossed: “Eli Lilly (LLY) options: 136 Dec 18 '26 $1200 calls traded at the bid for $3.22M”. The stock fell 0.51% in the next 10 minutes.

How far did LLY move after the headline?

From $1,427.10 just before the headline to $1,419.86 10 minutes later, a -0.51% move.

What else has moved LLY stock recently?

The two largest measured reactions before November 17, 2026: Nov 9, 2026, In a late-stage trial, Eli Lilly (LLY) says Zepbound, its obesity pill, significantly eased obstructive sleep apnea severity among patients with obesity. (+0.60% in 10 minutes); Nov 11, 2026, Eli Lilly (LLY) options: 140 Jan 2028 $2000 calls traded at the bid for $1.28M, above open interest of 132 (-0.38% in 10 minutes).

Sources

Follow LLY live

The live feed pairs breaking headlines with measured price moves. Build a watchlist of stocks you own and choose whether matching news reaches your WhatsApp.

Open the live feed See portfolio WhatsApp alerts
The next market-moving story will not wait

See the important story while it still matters.

Seven market specialists bring experience dating back to 2006. MoveSurge adds the speed, coverage, and clear format built for today’s market.

Core market coverageEquities, macro, currencies and commodities Clear in secondsThe story, source, context, and measured move together Built on evidenceReal headlines, timestamps, prices, and trusted sources
Go real time View the live feed Subscription renews automatically. Cancel before renewal. Information only—no trade calls.